You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

acral melanoma

Showing 1 - 25 of 2,526
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acral Melanoma Trial (camrelizumab+apatinib+TMZ, camrelizumab+apatinib, camrelizumab)

Not yet recruiting
  • Acral Melanoma
  • (no location specified)
Mar 16, 2023

Melanoma, Acral Melanoma, Temozolomide Trial (Camrelizumab)

Not yet recruiting
  • Melanoma
  • +6 more
  • (no location specified)
Aug 21, 2022

Acral Melanoma, Mucosal Melanoma Trial in Seoul (Pembrolizumab, Vactosertib)

Not yet recruiting
  • Acral Melanoma
  • Mucosal Melanoma
  • Pembrolizumab, Vactosertib
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Jun 23, 2022

Metastatic Melanoma, Unresectable Melanoma, Acral Melanoma Trial in Tampa (TBio-4101, Cyclophosphamide, Fludarabine)

Recruiting
  • Metastatic Melanoma
  • +9 more
  • TBio-4101
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 24, 2023

Acral Melanoma Trial in Changchun (SHR-1210+Apatinib)

Recruiting
  • Acral Melanoma
  • Changchun, Jilin, China
    The first hospital of Jilin University
May 24, 2021

Acral Lentiginous Melanoma Trial in Hong Kong (pembrolizumab)

Active, not recruiting
  • Acral Lentiginous Melanoma
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Prince of Wales Hospital
Feb 15, 2022

Locally Advanced or Metastatic Acral Malignant Melanoma Trial in Jinan (Toripalimab and Anlotinib)

Not yet recruiting
  • Locally Advanced or Metastatic Acral Malignant Melanoma
  • Toripalimab and Anlotinib
  • Jinan, Shandong, China
    Qilu Hospital of Shandong University
Oct 8, 2021

Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +20 more
  • Neoantigen Peptide Vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 7, 2022

Unresectable, Recurrent or Metastatic Melanoma, Untreated Mucosal or Acral Lentiginous Melanoma Trial in China (MGD013)

Terminated
  • Unresectable, Recurrent or Metastatic Melanoma
  • Untreated Mucosal or Acral Lentiginous Melanoma
  • Beijing, Beijing, China
  • +12 more
Apr 12, 2022

Acral Lentiginous Melanoma, CNS Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Houston (Nivolumab)

Active, not recruiting
  • Acral Lentiginous Melanoma
  • +9 more
  • Biospecimen Collection
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2023

Malignant Melanoma Trial in United Kingdom (PLX3397)

Completed
  • Malignant Melanoma
  • Manchester, Greater Manchester, United Kingdom
  • +7 more
Aug 11, 2021

Acral Melanoma That Has Been Removed by Surgery Trial in Beijing (IBI310+IBI308, IBI308, High-dose recombinant interferon a-2B)

Recruiting
  • Acral Melanoma That Has Been Removed by Surgery
  • Beijing, China
    Beijing cancer hospital
Jun 22, 2020

Cutaneous Melanoma, Mucosal Melanoma, Ocular Melanoma Trial in New York, Houston (biological, other, procedure)

Active, not recruiting
  • Cutaneous Melanoma
  • +10 more
  • Ipilimumab
  • +4 more
  • New York, New York
  • +1 more
Aug 25, 2021

Breast Cancer, Colorectal Cancer, Ovarian Cancer Trial in United States (ATRC-101, Pembrolizumab, Pegylated liposomal

Recruiting
  • Breast Cancer
  • +15 more
  • ATRC-101
  • +2 more
  • Phoenix, Arizona
  • +10 more
Sep 28, 2022

Unresectable Melanoma, Metastatic Melanoma Trial in Orlando, Louisville, New York (Lifileucel)

Available
  • Unresectable Melanoma
  • Metastatic Melanoma
  • Lifileucel
  • Orlando, Florida
  • +2 more
Jul 19, 2022

Acral Lentiginous Melanoma, Mucosal Melanoma Trial in Washington, Tampa, Hackensack (Nivolumab, Ipilimumab)

Unknown status
  • Acral Lentiginous Melanoma
  • Mucosal Melanoma
  • Washington, District of Columbia
  • +3 more
Jan 7, 2020

Advanced Acral Malignant Melanoma Trial in Beijin (Anlotinib, TQB2450)

Unknown status
  • Advanced Acral Malignant Melanoma
  • Beijin, Beijing, China
    Beijing Cancer Hospital
Oct 29, 2019

Acral Lentiginous Melanoma, Cutaneous Nodular Melanoma, Lentigo Maligna Melanoma Trial in United States (Dinaciclib)

Active, not recruiting
Has Results
  • Acral Lentiginous Melanoma
  • +6 more
  • Mobile, Alabama
  • +190 more
Jan 28, 2023

Advanced Melanoma Trial (Tebentafusp, Tebentafusp with Pembrolizumab, Investigators Choice)

Not yet recruiting
  • Advanced Melanoma
  • (no location specified)
Sep 19, 2022

Cancer, Melanoma Trial in Worldwide (Dabrafenib, Trametinib)

Completed
Has Results
  • Cancer
  • Melanoma
  • Guangzhou, Guangdong, China
  • +12 more
Jan 4, 2022

Acral Lentiginous Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Cutaneous Melanoma Trial in United States

Recruiting
  • Acral Lentiginous Melanoma
  • +6 more
  • Birmingham, Alabama
  • +309 more
Nov 8, 2021

Mucosal Lentiginous Melanoma, Acral Melanoma, Melanoma Trial in United States (Nilotinib)

Completed
Has Results
  • Mucosal Lentiginous Melanoma
  • +2 more
  • Santa Monica, California
  • +7 more
Oct 16, 2018

Melanoma Trial in Seoul (regorafenib)

Recruiting
  • Melanoma
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System
Apr 1, 2021

Acral Lentiginous Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in

Active, not recruiting
  • Acral Lentiginous Melanoma
  • +3 more
  • Biospecimen Collection
  • +4 more
  • Birmingham, Alabama
  • +822 more
Jan 28, 2023

Actinic Keratoses, Photodamaged Skin Trial in Truro (Ameluz)

Suspended
  • Actinic Keratoses
  • Photodamaged Skin
  • Truro, Cornwall, United Kingdom
    Royal Cornwall Hospital
Jul 29, 2022